ProviderMatters

MassHealth Drug Utilization Review (DUR) Program

Posted on April 7, 2025

Updates Notes
MassHealth

 

 All CAR-T drugs transition to the MassHealth Drug Utilization Review (DUR) Program

  • Effective April 1, 2025, MassHealth will transition the review and management of all CAR-T drugs to the MassHealth Drug Utilization Review (DUR) Program.
  • Health New England will continue to review all other services related to CAR-T.
  • The Chimeric Antigen Receptor Therapy policy will be updated to reflect this change.

 

Print PDF

Categories: Provider Newsletter

No Comments

Comments are currently closed.